Improving cancer communication in Rwanda
Validation of Quality Measures for Patient-Centered Cancer Communication in Rwanda
This study is all about making conversations between cancer patients and their doctors better in Rwanda, so patients can feel more supported and involved in their care, which can help them stick to their treatment and feel better overall.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11034097 on NIH RePORTER |
What this research studies
This research focuses on enhancing patient-centered communication (PCC) in cancer care in Rwanda, where many patients present with advanced disease and face significant treatment challenges. The project aims to adapt and validate a patient survey that measures the quality of communication between patients and healthcare providers. By involving patients in decision-making and providing emotional support, the research seeks to empower both patients and clinicians. The ultimate goal is to improve treatment adherence and outcomes through better communication practices.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients in Rwanda who are receiving treatment and can provide feedback on their communication experiences.
Not a fit: Patients outside of Rwanda or those not currently undergoing cancer treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment outcomes and patient satisfaction in Rwanda.
How similar studies have performed: Previous research has shown that enhancing patient-centered communication can significantly improve treatment adherence and outcomes in various healthcare settings.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Deboer, Rebecca — University of California, San Francisco
- Study coordinator: Deboer, Rebecca
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.